Our passion is to invent solutions to live longer, healthier lives
NOVOS leverages science and data to provide the best nutraceuticals, tests & knowledge to extend human healthspan and lifespan
Longevity supplements have fallen short in delivering true anti-aging results, relying on outdated concepts, ineffective ingredients and sub-optimal combinations and dosages. But at NOVOS, we’re changing the game.
We understand that addressing aging goes beyond simplistic combinations of ingredients and requires a deep understanding of its biological causes and a multi-faceted approach. That’s why studies demonstrate such promising results for our first-of-their-kind longevity formulations. By carefully targeting multiple causes of aging simultaneously, we create synergistic effects that go beyond individual components.
While most companies don’t invest the resources, our R&D team takes the care to prove out the efficacy of our patent-pending formulations with multiple third-party in vivo and in vitro human scientific studies.
And we don’t stop there. Longevity goes beyond novel formulations and taps into every aspect of life. We offer the tools, infrastructure and knowledge for everyone, regardless of where they are in the world, financially or in their life’s journey, to slow their aging and extend their healthspan and lifespan.
We believe in a new era of longevity, where science and innovation converge helping you be Younger For Longer.
Redefining Longevity Solutions
At NOVOS, we believe that science holds the key to slowing down aging. That’s why we designed the world’s first solution to simultaneously address the 12 scientifically proven root causes of aging.
Based on The Best Available Science
NOVOS solutions are designed to revolutionize the way we approach aging.
Created With The World’s Top Experts
NOVOS’ scientific advisors are biochemists, geneticists and professors from Harvard, MIT, University of Liverpool, University of Washington, and other universities around the world.
Using Scientifically Validated Ingredients
Made of 13 natural, FDA-approved ingredients that synergistically target 12 causes of aging.
Our Scientific & Medical Advisors and Consultants
Our world-renowned team of longevity scientists and doctors developed innovative supplements to slow your aging and unlock your vitality. With ongoing, cutting-edge research, we continue to offer you new possibilities.
Dr. George Church, PhD
Harvard Medical School & MIT Professor
Dr. George Church published the first direct genomic sequencing method in 1984 and is known as the “father” of synthetic biology and personalized genomics. Dr. Church has received various accolades, which include election to the National Academy of Sciences and the National Academy of Engineering. He is a recipient of the American Society for Microbiology Promega Biotechnology Research Award. His most cited work has been published in peer reviewed scientific journals including PNAS, Nature Genetics, Nature Biotechnology, Science, the Journal of Molecular Biology, Nature, and many others.
Dr. Pamela Maher, PhD
University of British Columbia, Salk Institute for Biological Studies
Dr. Maher worked for 5 years as an assistant professor at the Whittier Institute for Diabetes and Endocrinology in La Jolla, CA, then moved to The Scripps Research Institute in 1994 as an associate professor. In 2004, she moved to her current position at The Salk Institute. Her research interests focus on using natural products such as flavonoids, small molecules that are widely distributed in fruits and vegetables, to maintain nerve cell function in the presence of toxic insults, especially in relation to Alzheimer’s, dementia & Parkinson’s.
Dr. J Pedro de Magalhaes, PhD
Harvard Medical School, University of Liverpool
Dr. de Magalhaes leads the Integrative Genomics of Aging Group at the Institute of Integrative Biology, University of Liverpool, UK. Dr. de Magalhaes completed his postdoc with genomics pioneer, Dr. George Church, at Harvard Medical School. He developed high-throughput approaches for studying aging, including computational tools and databases, statistical models of mortality, and comparative genomics methods for investigating the evolution of longevity. Dr. de Magalhaes maintains several databases related to the impact that drugs & natural substances have on aging.
Dr. Oliver Medvedik, PhD
Harvard Medical School, The Cooper Union
Director of the Kanbar Center for Biomedical Engineering, Cooper Union. Dr. Medvedik has worked as a biotechnology consultant at Sirtris Pharmaceuticals and has taught molecular and synthetic biology while at Harvard University, The Cooper Union, School of Visual Arts, Genspace and NYU. He is also co-founder and vice-president of the non-profit organization LEAF (Life Extension Advocacy Foundation), where he serves on the board of directors. Dr. Medvedik performed his doctoral research at Dr. David Sinclair’s Harvard lab, and is a coauthor on multiple papers including studies on NAD+ and calorie restriction.
Dr. Avi Rosenbaum, PhD
Harvard Medical School
Scientist and Consultant, with deep knowledge of the biotech industry. Experience and international network in Genomics, Personalized Medicine, Gene Therapy and Synthetic Biology. Built the first academic Next Generation Sequencing platform. Launched more than ten commercial products. Investor and mentor in biotech, pharma, medical and food-tech companies. Holder of five patents, and co-author of high-profile academic publications with over 2,500 citations.
Dr. Robert Lufkin, MD
USC School of Medicine
Dr. Lufkin is Chief of Metabolic Imaging at a medical network in California and a distinguished Professor of Radiology at the USC School of Medicine, with over 200 peer-reviewed scientific papers to his credit and 14 books published. Dr. Lufkin has held several prestigious professional affiliations, including the presidency of the Society of Magnetic Resonance Imaging and the American Society of Head and Neck Radiology. He is also the inventor of several patents in artificial intelligence, including the globally-used MR-compatible biopsy needle, the “Lufkin Needle.”
Dr. Matt Kaeberlein, PhD
Massachusetts Institute of Technology, University of Washington — Consultant
Professor of Pathology, Adjunct Professor of Genome Sciences, and Adjunct Professor of Oral Health Sciences at the University of Washington, Dr. Kaeberlein’s research interests focus on basic mechanisms of aging in order to identify interventions that promote healthspan and improve quality of life. He has published nearly 200 papers in top scientific journals and has been recognized by prestigious awards, including Breakthroughs in Gerontology, Alzheimer’s Association Young Investigator Award, Ellison Medical Foundation New Scholar in Aging, a Murdock Trust Award, Pioneer in Aging, and Vincent Cristofalo Rising Star in Aging Research.
NOVOS is the scientific leader in longevity with a mission to add a billion years of healthy life to humanity by making the latest scientific advances in longevity accessible and achievable by all.
Relentlessly researched and vetted products you can trust
500+ studies
Ingredients backed by more than 500 longevity focused scientific studies + independent lab experiments
Expert Formulated & Tested
Formulation developed and tested by the world’s top regarded longevity scientists & doctors
Highest Quality Standards
Each ingredient as well as the finished products are tested for purity and to be free of toxins
A commitment beyond commerce
As a Public Benefit Corporation and as part of our ongoing longevity efforts, we donate a portion of our profits and equity to nonprofits such as the 501(c)(3), Lifespan Extension Advocacy Foundation (LEAF). We also create free educational content and digital tools to raise awareness and increase healthier living.
Our Scientific Leadership Team
A mission to make the latest scientific advances in longevity accessible and achievable for all. Our passion is to find solutions to live longer, healthier lives.
Chris Mirabile
Founder & CEO
Chris Mirabile graduated from NYU Stern School of Business and later won their business plan competition with his startup company, Hotlist, a location-based social network that scaled to 220 million people’s social plans. Chris has launched multiple successful technology ventures, and has advised biotech startups and NYU Langone Hospital. Chris’ interest in health began when he was 12, and evolved into a passion after he was cured of a brain tumor when he was 16. Chris has researched and integrated longevity practices and interventions into his life for more than ten years, has achieved a biological age 13.6 years younger than his chronological age, and according to epigenetic tests like DunedInPACE, is aging 31% slower biologically than chronologically.
Dr. Diogo Barardo, PhD
NOVOS Head of R&D, National University of Singapore
Diogo Barardo, PhD is a distinguished longevity researcher, machine learning expert, and former Postdoctoral Research Fellow at Professor Brian Kennedy’s renowned Center for Healthy Longevity at the National University of Singapore. Diogo authored the first paper of machine learning on predicting anti-aging compounds. He also created DrugAge, the world’s largest database of longevity-enhancing compounds. Diogo’s work ranges from C. elegans to mice to humans and has been cited in over 1,300 research papers.
We've got you covered
Go beyond the longevity solutions and get an insider view of the latest breakthrough science. NOVOS is a Public Benefit Corporation that provides science-based tips, actionable guidance, and expert-backed tools to the public for free.
Join our NOVOS community today to be Younger For Longer!